Literature DB >> 5000612

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.

M I Marks, R Prentice, R Swarson, E K Cotton, T C Eickhoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5000612     DOI: 10.1016/s0022-3476(71)80401-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  17 in total

Review 1.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  Gene amplification induces mucoid phenotype in rec-2 Pseudomonas aeruginosa exposed to kanamycin.

Authors:  V Deretic; P Tomasek; A Darzins; A M Chakrabarty
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

Review 3.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

4.  Pediatric antimicrobial therapy. II.

Authors:  M I Marks; R M Shapera; M Brazeau
Journal:  Can Med Assoc J       Date:  1973-07-21       Impact factor: 8.262

Review 5.  Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).

Authors:  E Bergogne-Berezin
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

7.  Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion.

Authors:  G Mombelli; L Coppens; J P Thys; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Gentamicin dosage in preterm and term neonates.

Authors:  B M Assael; V Gianni; A Marini; P Peneff; F Sereni
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

9.  Bronchial secretion levels of amikacin.

Authors:  W L Dull; M R Alexander; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.